Avista Capital Partners Acquires Taconic Biosciences

H.I.G. Capital Acquires Taconic Biosciences

February 7, 2019

Healthcare Services

H.I.G. Capital, through an affiliate, has completed the acquisition of Taconic Biosciences, a global provider of genetically engineered research models and related services. The private equity investment will partner with Taconic's management to support geographic expansion, broaden product and service offerings, and accelerate M&A-driven growth.

Taconic Biosciences Acquires TransCure bioServices

January 20, 2026

Biotechnology

Taconic Biosciences has acquired TransCure bioServices SAS to create an integrated global translational research platform combining Taconic's genetically engineered and humanized mouse models with TransCure's preclinical in vivo services. The deal expands Taconic's capabilities across oncology, immunology, infectious disease, and advanced modalities while preserving TransCure's brand and operational structure to ensure continuity for employees and clients.

Edgewater Capital Partners Acquires Haematologic Technologies

October 11, 2019

Biotechnology

Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.

H.I.G. Capital Acquires BioVectra Inc.

November 4, 2019

Pharmaceuticals

H.I.G. Capital, through an affiliate, completed the acquisition of BioVectra Inc., a Canadian contract development and manufacturing organization (CDMO) specializing in active pharmaceutical ingredients (APIs), intermediates and biologics. The deal — a carve-out from Mallinckrodt — positions H.I.G. to support BioVectra's growth and further expand its manufacturing capabilities across Charlottetown, Prince Edward Island and Windsor, Nova Scotia.

Avista Healthcare Partners Acquires EBI Bone Healing Division from Highridge Medical

June 4, 2025

Medical Devices

Avista Healthcare Partners has acquired EBI, the bone healing division of Highridge Medical, marking Avista's 50th platform healthcare investment. The deal is a carve-out/divestiture from Highridge (a H.I.G. Capital portfolio company) intended to position EBI as a standalone leader in bone growth stimulation technologies.

Avista Capital Partners Acquires GCM Holding Corporation

September 3, 2019

Medical Devices

Avista Capital Partners has acquired GCM Holding Corporation, an outsourced manufacturer of high-precision components and assemblies serving the MedTech, aerospace and diversified industrial markets, from May River Capital. The purchase gives Avista control of GCM’s three manufacturing facilities (including its Union City, California headquarters) as it seeks to invest in operational capacity and drive growth in medical device manufacturing.